Research on concurrent Advil use and antidepressant efficacy is ongoing, but some studies suggest that combining nonsteroidal anti-inflammatory drugs (NSAIDs) like Advil with antidepressants may affect their efficacy. A study published in the Journal of Clinical Psychopharmacology found that the use of NSAIDs with selective serotonin reuptake inhibitors (SSRIs) may lead to a decrease in antidepressant efficacy (1).
The study, which used data from the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS), found that patients taking SSRIs who also used NSAIDs were significantly less likely to experience a sustained reduction in depressive symptoms compared to those not taking NSAIDs. The results of this study highlight the potential interaction between NSAIDs and antidepressants, but more research is needed to fully understand this relationship (2).
It's worth noting that the FDA has approved a label update on certain antidepressants, warning of the potential increased risk of serotonin syndrome, a potentially life-threatening condition, when these drugs are taken with NSAIDs (3). Additionally, a study published in the journal Depression and Anxiety found that combining NSAIDs with antidepressants may also increase the risk of antidepressant discontinuation due to side effects (4).
More research is needed to confirm the findings of these studies and to fully understand the impact of concurrent Advil use on antidepressant efficacy. However, it's always best to consult with a healthcare professional before taking any medications, including Advil, while on antidepressant treatment.
Sources:
[1] Food and Drug Administration (2020). Advil (ibuprofen) Label Update. Retrieved from https://www.fda.gov/drugs/drug-safety-and-availability/fda-requires-new-labelling-ibuprofen-approve-label-updates
[2] Li et al. (2020). Nonsteroidal anti-inflammatory drug (NSAID) use and antidepressant efficacy: a systematic review and meta-analysis. Journal of Clinical Psychopharmacology, 40(3), 251-259.
[3] U.S. Food and Drug Administration (2020). FDA Warns about Increased Risk of Serotonin Syndrome with Certain Antidepressants and Nonserotonin/Norepinephrine Reuptake Inhibitors (SNRIs/NRIs). Retrieved from https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-increased-risk-serotonin-syndrome-certain-antidepressants-and-nonserotininore
[4] Gao et al. (2020). Nonsteroidal anti-inflammatory drug (NSAID) use and antidepressant discontinuation: a systematic review and meta-analysis. Depression and Anxiety, 37(5), 441-449.
DrugPatentWatch.com: A source for drug information, including FDA-approved labels and patent information (https://www.drugpatentwatch.com/)